Lymphoproliferative disorders: CT findings in immunocompromised children

American Journal of Roentgenology

Volumn 171, Issue 3, 1998, Pages 725-731

  Donnelly, Lane F ^a   Frush, Donald P ^a   Marshall, Kelley W ^b   White, Keith S ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031751735     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.3.9725305     Document Type: Article

References (30)

1. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988;25: 365-472
2. List AF, Greco FA, Vogler LB. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J Clin Oncol 1987;5: 1673-1689
3. Rickinson AB. Cellular immunologic response to the virus infection. In: Epstein MA, Achong BG, eds. The Epstein-Barr virus: recent advances. New York: Wiley, 1986:72-125
4. Bragg DG, Chor PJ, Murray KA, Kjeldsberg CR. Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features. AJR 1994;163:273-281
5. Harris KM, Schwartz ML, Slasky BS, Nalesnik MA, Makowka L. Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations. Radiology 1987;162:697-700
6. Tubman DE, Frick MP, Hanto DW. Lymphoma after organ transplantation: radiologic manifestations in the central nervous system, thorax, and abdomen. Radiology 1983;149:625-631
7. Mulvihill DM, Munden MM, Edell D. Lymphoproliferative disorder involving the liver following transplantation: CT appearance. J Comput Assist Tomogr 1994;18:47-48
8. Heitzman ER. Pulmonary neoplastic and lymphoproliferative disease in AIDS: a review. Radiology 1990;177:347-351
9. McGuinness G, Scholes JV, Jagirdar JS, et al. Unusual lymphoproliferative disorders in nine adults with HIV or AIDS: CT and pathologic findings. Radiology 1995;197:59-65
10. Day DL, Shapiro RS, Yueh N, McClain K, Allan BT, Filipovich AH. B-cell lymphoproliferative disorders in children after bone marrow transplantation: radiologic manifestations. Radiology 1987;162:807-810
11. Carignan S, Staples CA, Muller NL. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology 1995; 197:53-58
12. Murray KA, Chor PJ, Turner JF. Intrathoracic lymphoproliferative disorders and lymphoma. Curr Probl Diagn Radiol 1996;25:77-106
13. Connolly BL, Sena LM, Smith C. The spectrum of lymphoproliferative disease (LPD) in children: recognition and diagnosis (abstr). Radiology 1997 [suppl];205:161
14. Dodd GD III, Ledesma-Medina J, Baron RL, Fuhrman CR. Posttransplant lymphoproliferative disorder: intrathoracic manifestations. Radiology 1992; 184:65-69
15. Purtilo DT. Opportunistic cancers in patients with immunodeficiency syndromes. Arch Pathol Lab Med 1987;111:1123-1129
16. Purtilo DT. Epstein-Barr virus-associated lymphoid and epithelial lesions occurring in the life cycle. In: Levine PH, Ablashi DV, Nonoyma M, et al., eds. Epstein-Barr virus and human disease. Clifton, NJ: Humana, 1987:3-11
17. Klein G, Klein E. Evolution of tumours and the impact on molecular oncology. Nature 1985;315: 305-328
18. Cooper GM. Molecular and functional analysis of Ras and Blym transforming genes. In: Wahren B, ed. Molecular biology of tumors. New York: Raven, 1985:1-7
19. Cooper MD, Bertoli LF, Borsillo GV. Pathogenesis of B cell malignancies. In: Gall RP, Golde DW, eds. Leukemia: recent advances in biology and treatment. New York: Alan R. Liss, 1985: 453-465
20. Schubach HW, Miller G, Thomas ED. Epstein-Barr virus genomes are restricted to secondary neoplastic cells following hone marrow transplantation. Blood 1985;65:535-538
21. Gossett TC, Gale RP, Fleischuman H, et al. Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N Engl J Med 1979;300: 904-907
22. Schubach WH, Hackman R, Neiman PE, et al. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for lymphoblastic leukemia. Blood 1985;160:180-187
23. Martin PJ, Shulman HM, Schulbach WH, et al. Fatal Epstein-Barr virus associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T cell antibody. Ann Intern Med 1984;101:310-315
24. Deeg HJ, Storb R, Thomas ED. Bone marrow transplantation: a review of delayed complications. Br J Haematol 1984;57:185-208
25. Bloom RE, Dinsmore R, O'Reilly RJ, et al. B-cell lymphoma of host origin in a marrow transplant (BMT) recipient in remission of acute myeloid leukemia (abstr). Blood 1982;60:165a
26. Spector BD, Perry GS, Kersey JH. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the Immunodeficiency-Cancer Registry. Clin Immunol Immunopathol 1980;11:12-29
27. Waldmann TA, Misiti J, Nelson DL, et al. Ataxiagelan-giectasia: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia. Ann Intern Med 1983;99:367-379
28. Waldmann TA, Broder S, Blaese RM, et al. Role of suppressor T-cells in the pathogenesis of common variable hypogammaglobulinemia. Lancet 1974;2: 609-613
29. Siegel FP, Siegel M, Good RA. Role of helper, suppressor and B cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med 1978;299:172-178
30. Chaganti RS, Jhanwar SC, Koziner B, Arlin Z, Mertelsmann R, Clarkson BD. Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood 1983;61:1265-1280